Clinical Trial Update: Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects

View source ↗

Summary

This completed trial update reports on treatment adherence outcomes for relapsing multiple sclerosis patients using the RebiSmart autoinjector with Rebif (inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis, MS | Status: COMPLETED